AGRF Appoints Dr Kirby Siemering as new CEO
/On behalf of the AGRF Board and AGRF staff, we are pleased to announce the appointment of Dr Kirby Siemering as Chief Executive Officer of the Australian Genome Research Facility. AGRF Board Chairman, Emeritus Professor Simon Foote says, “The board is delighted that Kirby Siemering has agreed to accept the offer of CEO for AGRF. Kirby has been Acting CEO for nearly 12 months and the board has been extremely impressed by the job he has done.
He has intimate knowledge of the workings of this organisation and is very well respected by genomics researchers across the country, which bodes well for the future of this country’s pre-eminent genomics organisation.”
With over 25 years’ experience as an executive manager in life sciences and genomics in both academic and commercial settings, Dr Siemering has held senior positions in academia and ASX-listed and privately held biotechnology companies, also gaining valuable experience in biotechnology industry analysis, strategy, and policy development with the Victorian State Government.
Dr Kirby Siemering, Chief Executive officer, agrf
Dr Siemering says, “I am delighted to have the opportunity to lead the organisation where I have worked for more than 15 years. I have always been passionate about the application of genomic technologies to real-world problems and look forward to helping AGRF continue our critical mission of working together with the genomics community to enable world-class science”.
Before joining AGRF in 2003, Dr Siemering worked as a Research Fellow at Murdoch Children’s Research Institute in the area of inherited hearing loss. Prior to that, he worked as a Policy Analyst at the Department of Innovation, Industry & Regional Development on the first Biotechnology Strategic Development Plan for Victoria and also held Principal Scientist positions at Florigene Ltd and ForBio Research Pty Ltd. Dr Siemering received his PhD in molecular biology from the University of Melbourne and completed post-doctoral training at the MRC Laboratory of Molecular Biology in Cambridge, UK.
Dr Siemering sits on the Board and Executive Management Committee of the Melbourne Genomics Health Alliance, the Executive Committee of the Australasian Genomic Technologies Association, and the Victorian Government’s Genomics Clinical Advisory Group.
Please join us in officially welcoming Dr Kirby Siemering to the role of CEO. We look forward to 2020 and beyond, and we wish Kirby every success.
